Prelude Capital Management’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-4,791
| Closed | -$7K | – | 1921 |
|
|
2016
Q2 | $7K | Buy |
+4,791
| New | +$7K | ﹤0.01% | 1380 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1782 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1921 |
|
|
2015
Q2 | – | Sell |
-1,800
| Closed | -$47K | – | 2180 |
|
|
2015
Q1 | $47K | Hold |
1,800
| – | – | 0.01% | 1266 |
|
|
2014
Q4 | $38K | Buy |
+1,800
| New | +$38K | 0.01% | 1360 |
|
|
2014
Q3 | – | Sell |
-1,100
| Closed | -$35K | – | 2162 |
|
|
2014
Q2 | $35K | Buy |
1,100
+500
| +83% | +$15.9K | ﹤0.01% | 1441 |
|
|
2014
Q1 | $28K | Sell |
600
-400
| -40% | -$18.7K | ﹤0.01% | 1430 |
|
|
2013
Q4 | $71K | Buy |
1,000
+500
| +100% | +$35.5K | 0.01% | 885 |
|
|
2013
Q3 | $43K | Buy |
+500
| New | +$43K | 0.01% | 838 |
|